VivoSeq
Metabolic & Endocrine

Thyroid

0

Pipeline Programs↗

4

Active Trials↗

3

Companies Involved↗

Thyroid is an early-stage landscape with 0 programs across 3 companies. The most active players are AbbVie, Innovo Therapeutics, Inc., Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

0 programs

PreclinicalI

Innovo Therapeutics, Inc.

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

53

clinical trials

Completed30 · 57%
Unknown status12 · 23%
Terminated5 · 9%
Recruiting3 · 6%
Withdrawn2 · 4%
Not yet recruiting1 · 2%

Clinical Trials

Trial Activity

53 trials

Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
Recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·N/A·NCT06652113·796 enrolled
Studies on Tumors of the Thyroid
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·N/A·NCT00001160·2,500 enrolled
Interest of Improving Preoperative Medical Information by Video Support and Personalized and Secure Web Platform: Pilot Study in Thyroid Surgery (AMEDOP)
Recruiting·UUniversity Hospital, Montpellier·Preclinical·NCT04571736·220 enrolled
Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC
Not yet recruiting·WWest China Hospital·Phase 3·NCT07239674·646 enrolled
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
Completed·AbbVie logoAbbVie·Phase 2·NCT04124705·284 enrolled
Improving White Matter Integrity With Thyroid Hormone
Completed·UUniversity of Illinois at Chicago·N/A·NCT04098991·5 enrolled
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
Completed·UUniversity of Colorado, Denver·Phase 1·NCT02278198·5 enrolled
Thyroid and Adrenocortical Hormone Replacement in Organ Donors
Completed·MMedical University of South Carolina·N/A·NCT04528797·199 enrolled
Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents
Completed·HHospices Civils de Lyon·N/A·NCT05151120·28 enrolled
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
Completed·UUniversity of Michigan·Phase 1·NCT00277706·40 enrolled
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
Completed·—·N/A·NCT01691781·41 enrolled
Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations
Completed·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT02457897·7 enrolled
The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
Completed·SSingapore Institute of Food and Biotechnology Innovation·N/A·NCT03064542·30 enrolled
Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone
Completed·Sanofi logoSanofi·Phase 1·NCT00137891·46 enrolled
Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
Completed·NNational Center for Research Resources (NCRR)·N/A·NCT00018135
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)